持续发展,向下一个百年迈进
我们竭尽全力以信息的透明度,公平度,可持续性作为基本,
及时发布企业信息。
IR Topics 最新IR信息
- 2024年3月26日 Announcement of Extraordinary Gains(Gain on Sale of Investment Securities)
- 2024年2月14日 FY2023 Third Quarter Financial Results Presentation Summary of Q&A Session
- 2024年2月7日 Announcement of Discontinuation of Development of a Norovirus Vaccine in an Overseas Consolidated Subsidiary and Recording of Extraordinary Loss
- 2024年2月7日 FY2023 Third Quarter Financial Results Presentation Materials
- 2024年2月7日 Notice Regarding Changes in Executive Officers
About use of IR information
The investor relations (IR) information on this website is presented in order to provide financial information, management indicators, and other data on Denka Company Limited. The company does not make no representation or warranties with regard to the content.
The IR information on this website does not constitute a solicitation of investment. In actual decisions on investment, investors are asked to refrain from depending entirely on this information and to make decisions based on their own independent examinations and judgments.
About future outlooks
Some of the information presented on this website includes statements about expected future performance. These statements do not guarantee any future result; and they contain factors of risk and uncertainty. Please note that actual future results could possibly differ from this future outlook, owing to changes in the environment and other circumstances.